Integral Diagnostics Limited

A$1.74As of Sun 8 Nov 2026, 12:00 UTC
ASX:IDXHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR 3.92%
Div yield 5.34%
ROE 3.21%
Diagnostics & Research
Beta (5Y) 0.23
PE TTM 30.00
TSR TTM (30.09%)
Mkt cap A$648.1M
ROIC 4.13%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.95
12.12%
(48.27%)
Hold 6|4|12|8|4
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.03
0.03
0.03
0.02
26.66%
18.73%
9.46%
(1.47%)
Revenue$M
33.56
33.92
35.22
36.24
16.20%
19.28%
17.14%
14.33%
Peers (US$445.1M)
Cap (US$)
PE
411.8M
26.28x
249.4M
—
198.0M
38.95x
404.9M
94.58x
Capital
TTM
5Y
10Y
Leveragex
1.882
1.375
1.024
EBIT/Intx
1.506
0.135
0.174
Own earn%
(41.58)
41.50
51.36
Sh yield%
47.14
27.56
23.52
Owners
Insiders/Inst%
11.32
66.48
Short interest%
2.94
SBC / revenue%
2.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
25–34
$1 testx
0.0
Incr. ROIC%
4